Xcelerating Life Sciences Fireside Chat
David Horton, director of Regulatory Affairs at Medpace, sits down with Xconomy Managing Editor Dan Stanton to discuss the importance of early planning for biotechs, and why engaging with a CRO at the right time can bring advantages to the development of a molecule.
Xconomy
2 International Place #2610
Boston, MA 02110-4104
WATCH FOR FREE: